These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 11144921)

  • 21. Current problems with intrahepatic bile duct stones in Japan--congenital biliary malformations as a cause.
    Fujii H; Yang Y; Matsumoto Y; Suda K
    Hepatogastroenterology; 1997; 44(14):328-41. PubMed ID: 9164499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.
    Boberg KM; Schrumpf E; Bergquist A; Broomé U; Pares A; Remotti H; Schjölberg A; Spurkland A; Clausen OP
    J Hepatol; 2000 Mar; 32(3):374-80. PubMed ID: 10735605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
    Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
    Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
    Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis.
    Caldwell SH; Bickston SJ
    Liver Transpl; 2001 Apr; 7(4):380. PubMed ID: 11303302
    [No Abstract]   [Full Text] [Related]  

  • 28. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
    Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
    Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
    de Groen PC
    Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholangiocarcinoma associated with hypercalcaemia and ascites presenting as sclerosing cholangitis.
    D'Costa DF
    Br J Clin Pract; 1994; 48(4):217-8. PubMed ID: 7917805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma.
    Komori J; Marusawa H; Machimoto T; Endo Y; Kinoshita K; Kou T; Haga H; Ikai I; Uemoto S; Chiba T
    Hepatology; 2008 Mar; 47(3):888-96. PubMed ID: 18306229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis.
    Varotti G; Gondolesi GE; Roayaie S; Suriawinata A; Soltys K; Fishbein TM; Schwartz ME; Miller C
    J Am Coll Surg; 2003 Nov; 197(5):765-9. PubMed ID: 14585411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M; Elinav H; Goldin E; Ilan Y
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.
    Ahrendt SA; Rashid A; Chow JT; Eisenberger CF; Pitt HA; Sidransky D
    J Hepatobiliary Pancreat Surg; 2000; 7(4):426-31. PubMed ID: 11180865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma.
    Shimonishi T; Miyazaki K; Kono N; Sabit H; Tuneyama K; Harada K; Hirabayashi J; Kasai K; Nakanuma Y
    Hum Pathol; 2001 Mar; 32(3):302-10. PubMed ID: 11274640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma.
    Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R
    Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis ?
    John AR; Haghighi KS; Taniere P; Esmat ME; Tan YM; Bramhall SR
    Dig Surg; 2006; 23(5-6):319-24. PubMed ID: 17170527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
    Linder S; Söderlund C
    Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.